JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties
ABSTRACTThe intensive study and investigation of neuroprotective therapy for central nervous system (CNS) diseases is ongoing. Due to shared mechanisms of neurodegeneration, a neuroprotective approach might offer benefits across multiple neurological disorders, despite variations in symptoms or inju...
Main Authors: | Yibeini Wu, Yiling Zhao, Ziman Guan, Sajjad Esmaeili, Zhicheng Xiao, Diji Kuriakose |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Cell Adhesion & Migration |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19336918.2024.2316576 |
Similar Items
-
GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis
by: Qianwei Zhao, et al.
Published: (2024-01-01) -
INVOLVEMENT OF JNK MAPK CASCADES IN THE FORMATION OF ADHESIONS IN THE ABDOMINAL CAVITY
by: I. A. Shurygina, et al.
Published: (2018-07-01) -
JNK Cascade-Induced Apoptosis—A Unique Role in GqPCR Signaling
by: Guy Nadel, et al.
Published: (2023-08-01) -
The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases
by: Jing Chen, et al.
Published: (2021-09-01) -
Discovery of a Potent and Selective JNK3 Inhibitor with Neuroprotective Effect Against Amyloid β-Induced Neurotoxicity in Primary Rat Neurons
by: Joonhong Jun, et al.
Published: (2021-10-01)